HOME CARE

Got an unsolicited offer for your home care agency? What to do

Answer it, but don't negotiate against yourself. Check who the buyer is and where its money comes from, share nothing detailed until an NDA is signed, and don't grant exclusivity before you have a written offer. Then quietly compare it with interest from a few other qualified home care buyers, because a single bidder sets the price, the structure and the deadline on its own.

The four types of home care buyers →Find out who is buying agencies like yours →

Akim Guennani

By Akim Guennani, Founder · Updated November 2026

Who is sending you this offer, and why now?

Most cold approaches to home care owners come from buyers who need add-on acquisitions to hit a growth plan. Private equity was involved in about 37 percent of the 110 home health and hospice deals LevinPro HC tracked in 2025, and one of the most active buyers on its list was Help at Home, a private equity-owned personal care company that added several personal care agencies that year. A platform that just entered your state, or one with a Medicaid managed care contract that covers your counties, often writes to every agency it can find there.

The sender tells you a lot about how the deal will go, so identify it before you reply.

PE-backed platform
A home care company owned by a private equity fund, buying agencies to add hours and territory. Usually closes, usually runs a full quality of earnings review, and often asks for an earnout or rollover.
Strategic regional operator
An agency or health system already serving nearby counties. It may pay more for density because it can fold your office into its own, and it is also the buyer most likely to be a competitor.
Search fund or independent sponsor
An individual or small team raising money for each deal, often with an SBA loan. Sincere, but the financing usually isn't committed yet.
Buyer-side intermediary
A banker, finder or "proprietary deal" sourcing firm writing on behalf of one or more buyers. Ask who the buyer is, who pays the intermediary, and whether you will ever be asked to sign a fee agreement.

How do you tell a serious buyer from a fishing expedition?

A serious buyer answers specific questions in writing without hesitating: who provides the capital, which home care, home health or hospice deals it has closed and in which states, and how it would finance yours. The full list of questions is in the table below. A buyer that can't name a closed home care deal, or that says it will "raise the money once we agree on terms," is still shopping.

Also ask why your agency. A real answer names something specific: your counties, your Medicaid waiver or managed care contracts, your private pay mix, your Medicare certification. A templated email that could have gone to a plumbing company is a mailing list, and you can answer it at your own pace.

What should you share before and after an NDA?

Before an NDA, share only what an anonymous summary would show: your service lines, the general area you serve, a revenue range and a rough payer mix. Don't send your name and license number together with financials, and never send client lists, caregiver rosters or pay rates, referral sources, or payer contract rates.

After an NDA, share what a buyer needs for a written range: trailing twelve months and two prior years of financials, adjusted EBITDA with your add-backs explained, billed hours or visits by payer, and caregiver headcount and turnover. Hold client names, individual caregiver pay and contract rates until a signed LOI, and if the buyer competes with you locally, until a clean team is set up. The FTC's guidance on pre-merger information sharing tells merging competitors to share the least information needed for due diligence, because they remain separate competitors until closing.

Read the NDA before you sign it. In home care the clauses that matter are a ban on hiring your caregivers and office staff, a ban on contacting your clients, referral sources and payers, and an end date. A buyer's standard NDA often protects the buyer more than you.

What do you lose by talking to only one buyer?

You lose your bargaining position. With one buyer, the buyer sets the price, the structure and the deadline, and your only alternative is to say no. That is why first numbers are often given on the phone, before the buyer has seen financials: "agencies like yours trade around six times" quietly becomes the most you can expect, and every later term is negotiated down from it.

The bigger risk comes after the LOI. Once you sign exclusivity, often 30 to 60 days and sometimes longer, you can't talk to anyone else. If the buyer's quality of earnings review finds that caregiver overtime was understated or an add-back doesn't hold, the buyer reduces the price, a move dealmakers call a re-trade or price chip. You can accept or start over months later, with staff who may have noticed the diligence visits. The same pressure moves value out of cash at closing and into an earnout or seller note.

Competition changes this even for the largest home care companies. In May 2023, Amedisys had a signed agreement to merge with Option Care Health in an all-stock deal. Optum then sent an unsolicited all-cash proposal of $100 per share, and in June Amedisys signed with Optum at $101 per share in cash, about $3.3 billion, and Option Care Health received a $106 million termination fee for giving up the first agreement. Your agency won't draw that kind of public bidding war, but the mechanism is the same: a second credible buyer is what improves both the price and the cash.

When is it fine to take the single offer?

Sometimes the buyer who called really is your best buyer. That is the case when it is the natural acquirer: it already serves the counties around yours, holds the same Medicaid waiver or managed care contracts, or needs your Medicare certification to enter the area. It is also fine when the price is clearly full against published ranges for your size and segment, or when speed and certainty matter more to you than the last half turn of EBITDA because of health, family, or a rate or wage change you see coming.

If you go ahead with one buyer, protect yourself in the LOI rather than in diligence. Get most of the price as cash at closing, keep exclusivity short, and write down the adjusted EBITDA the price is based on, so any reduction has to point to a specific diligence finding. Ask that exclusivity end automatically if the buyer proposes a lower price, fix how the working capital target will be set, and require proof of committed financing. Have a healthcare M&A attorney review the LOI before you sign, along with a CPA for the tax side.

Where Lartico Capital fits

Lartico Capital lets you put the approach next to interest from other qualified home care buyers without listing the agency. We tell you which other buyers fit and, with your approval, make private introductions. Your identity is shared only after you approve a buyer and it signs an NDA. You can keep talking to the buyer that contacted you the whole time.

Owners pay nothing and sign no exclusivity agreement with Lartico Capital; the buyer pays Lartico Capital's fee at closing. Lartico Capital is not a broker and doesn't negotiate for you, so your own attorney and accountant still matter.

Questions to ask the buyer before you share anything

Send these by email so the answers are in writing. How quickly and specifically the buyer answers tells you as much as the answers do.

QuestionA serious buyer saysWarning sign
Who provides the capital?The named fund, owner or lender, and whether equity is already committed"We have investors lined up" or no name
Which home care deals have you closed, and where?Specific agencies or counts, by state and service lineOnly deals outside home care, or none
How will this deal be financed?Cash on the balance sheet or an existing credit line; for SBA-backed buyers, the lender's nameFinancing to be found after an LOI
What do you need before giving a written range?A short, specific list of financial and operating dataClient lists, caregiver pay or license numbers before an NDA
What is your timeline to close?Steps with rough dates, including state licensing and payer change of ownership filingsPressure to sign this week
Will you pay for the quality of earnings review?Yes, as part of its own diligenceExpects you to pay, or skips diligence and promises a quick close

How a $6 million headline shrinks with one buyer

This is how a single-buyer deal typically erodes: a number on the phone, an LOI built on it, exclusivity, and then a price that moves once the buyer's accountants arrive. Each step is small, and no single one feels like a reason to walk away.

Illustrative example: one buyer, no competition

A personal care and home health agency with about $9 million of revenue reports $1,000,000 of adjusted EBITDA. A platform calls and says agencies like this trade around 6x, or $6,000,000. Its LOI offers $6,000,000: $4,200,000 cash at closing, a $1,200,000 earnout tied to two years of revenue targets, and a $600,000 seller note subordinated to its bank, with 75 days of exclusivity. Fifty days in, its quality of earnings review finds $70,000 of unrecorded caregiver overtime and disallows a $50,000 add-back for the owner's spouse, who runs scheduling and will need to be replaced. Adjusted EBITDA is now $880,000, and the buyer reprices at the same 6x: $5,280,000. It keeps the earnout and note at $1,800,000, so cash at closing falls to $3,480,000. A 10 percent indemnity escrow ($528,000) and a $90,000 working capital shortfall leave $2,862,000 paid at closing, under half of the $6,000,000 headline, before taxes and the owner's own fees. The rest depends on hitting earnout targets and on the buyer paying a note that ranks behind its lender. The figures are hypothetical.

What competitive tension can change

Competition doesn't make problems in the numbers disappear. What it changes is who absorbs them and how much of the price is paid in cash. The owner below found the same issues before going to buyers, so no buyer had a surprise to re-trade on.

Illustrative example: the same agency with three buyers

The owner's accountant restates adjusted EBITDA to $880,000 before any buyer sees it. Three buyers submit written offers in the same three weeks. The original platform offers 6.25x, or $5,500,000: $5,000,000 cash and a $500,000 note. A regional operator serving the neighboring counties, which can merge the two offices, offers 6.5x, or $5,720,000: $5,200,000 cash and a $520,000 earnout. A second platform offers 6.0x, or $5,280,000, all cash. The owner signs with the regional operator for 45 days of exclusivity and agrees on the working capital target in the LOI. After the same 10 percent escrow ($572,000), cash at closing is $5,200,000 minus $572,000, or $4,628,000. That is $1,766,000 more cash at closing than in the single-buyer example, on a headline price $280,000 lower. The figures are hypothetical.

How to test the offer quietly, step by step

None of this needs a public listing or an auction. The goal is two or three credible written offers, compared side by side within a few weeks, while the original buyer stays interested. This is general guidance, not legal or tax advice.

Owner checklist

  • Reply to the original buyer within a few days, warmly and without numbers (sample reply below).
  • Hire a healthcare M&A attorney to review the buyer's NDA, adding no-hire and no-contact clauses and an end date.
  • Pull the trailing twelve months of financials and restate adjusted EBITDA with your accountant, looking for the issues a buyer's QoE would find: caregiver overtime, owner and family pay, one-time revenue, and rate changes.
  • List the other buyers that fit: platforms already buying in your state, regional operators near your counties, and buyers looking for your payer mix. Lartico Capital can tell you who buys agencies like yours.
  • Show them an anonymous summary first, and reveal your name only to buyers you approve after they sign an NDA.
  • Give every party, including the original buyer, the same data and the same date for a written range or LOI, three to four weeks out.
  • Compare offers on cash at closing, earnout and note terms, exclusivity length, financing, and conditions such as state licensing and payer approvals.
  • Pick one, negotiate the LOI with short exclusivity, and tell the others politely that you have chosen another buyer.

Sample replies to the buyer who called

First reply, to keep the buyer interested without granting anything: "Thanks for reaching out. I'm not running a sale, but I'm open to a conversation. Before I share financials, please send your NDA and a short note on your capital source, the home care deals you've closed and where, and what you'd need to give me a written range. I'm not in a position to agree to exclusivity at this stage."

If the buyer pushes for exclusivity or a fast answer: "I understand you want certainty before you spend on diligence. I'll consider exclusivity once I have a written LOI I'm prepared to sign, with the cash at closing, any earnout or note, how working capital will be set, and a short exclusivity period. I'm expecting to make a decision by [date], and I'd like your proposal to be part of it."

Neither reply names other buyers or invents offers. A serious buyer will work to your date.

Red flags in an unsolicited approach

One of these alone doesn't make a buyer a bad partner, but two or three together usually mean a slow, expensive process with a poor chance of closing.

Owner checklist

  • A price given before the buyer has seen any financials, especially "up to" a number
  • Exclusivity or a no-shop clause asked for before a written LOI
  • An offer that expires in days, with no reason tied to the buyer's own deadlines
  • A buyer that wants to speak with your scheduler, nurses or caregivers before you have agreed to sell
  • An intermediary that asks you, the seller, to sign a fee agreement or pay anything
  • Most of the price in an earnout or seller note while the headline is the only number repeated

If the buyer uses an SBA loan, what is your seller note worth?

Often far less than its face value suggests, so ask how the note fits the lender's rules before you agree to one. This matters when the buyer is an individual or a search fund financing the purchase with an SBA 7(a) loan. Under SBA's current lending rules (SOP 50 10 8.1, in effect for loans from October 1, 2026), a seller note can count toward the buyer's required equity only if it is subordinated to the lender and on full standby: no principal or interest payments for the entire term of the SBA loan. Interest can accrue and be paid after the SBA loan is repaid.

The same rules require at least 10 percent equity on a first acquisition and let standby debt and similar sources cover no more than half of it. A note that is not on standby counts as debt instead, and SBA caps total acquisition debt at the business valuation, so it can also limit the price the buyer can pay. A note you can't collect on for years is a very different asset from one paid monthly; the seller-notes guide covers the other terms to negotiate.

Sources and methodology

Public transactions provide market context, not a valuation quote for a private practice. Illustrative examples use hypothetical assumptions and are not predictions. This guide is educational and is not legal, tax, accounting, or investment advice.

  1. 1. Most active buyers in the home health & hospice sector (LevinPro HC (Irving Levin Associates)). 110 home health and hospice transactions announced in 2025; private equity involved in about 37 percent. Help at Home, backed by Centerbridge Partners and The Vistria Group, is listed among the most active 2025 buyers, with deals focused on personal care services.
  2. 2. Amedisys announces receipt of unsolicited proposal from Optum (Form 8-K, Exhibit 99.1) (Amedisys via SEC EDGAR). May 26, 2023 unsolicited all-cash proposal at $100 per share while Amedisys was party to an all-stock merger agreement with Option Care Health signed May 3, 2023.
  3. 3. Amedisys Form 8-K, June 26, 2023 (merger agreement with UnitedHealth Group; termination of Option Care Health agreement) (Amedisys via SEC EDGAR). Option Care Health merger agreement terminated on payment of a $106 million termination fee.
  4. 4. Amedisys and Optum to combine (Form 8-K, Exhibit 99.1) (Amedisys via SEC EDGAR). June 26, 2023 agreement for an all-cash acquisition at $101 per share.
  5. 5. Optum to acquire Amedisys in all-cash transaction (Home Health Care News). Deal valued at roughly $3.3 billion; Optum's earlier bid was $100 per share.
  6. 6. Avoiding antitrust pitfalls during pre-merger negotiations and due diligence (Federal Trade Commission, Bureau of Competition). Share the least information needed for due diligence; use clean teams and aggregated data; merger parties remain independent until closing.
  7. 7. Global Private M&A Guide: United States, preliminary documents (Baker McKenzie). Exclusivity commonly spans 30 to 60 days after the letter of intent is signed; LOIs are typically non-binding apart from provisions such as confidentiality.
  8. 8. SOP 50 10: Lender and Development Company Loan Programs (Version 8.1, effective October 1, 2026) (U.S. Small Business Administration). Seller debt counts as equity only if subordinated and on full standby (no principal or interest for the term of the 7(a) loan); limited equity sources may provide no more than half of the required injection; 10 percent minimum injection for initial acquisitions; total debt, including seller debt not on full standby, limited to the business valuation.

Reviewed November 2026

Questions owners ask

Straight answers, before you commit to anything.

Should I ignore an unsolicited offer for my home care agency?+

Don't ignore one from a buyer with closed home care deals and real capital, even if you aren't ready to sell. A short, polite reply keeps the door open, tells you who is active in your market, and commits you to nothing.

Should I tell the buyer what price I want?+

No, not first. Any number you give tends to become your ceiling. Ask the buyer to put a written range on paper after it has seen financials under an NDA.

Is it bad faith to talk to other buyers after one approached me?+

No. Until you sign an LOI with an exclusivity clause, you have no obligation to the buyer that called you, and experienced buyers expect owners to compare options.

How long should exclusivity last?+

Ask for the shortest period that fits the buyer's diligence plan. Law firm guidance puts the common range at 30 to 60 days after the LOI, and longer periods are worth tying to milestones the buyer has to meet.

What if the buyer is a local competitor?+

Be strictest with information: no-hire and no-contact clauses in the NDA, and client lists, caregiver pay and payer rates only to a clean team after an LOI, since a competitor could use them if the deal falls apart.

Do I need a broker to respond to an unsolicited offer?+

No. You need a healthcare M&A attorney before you sign an NDA or LOI and an accountant who can defend your adjusted EBITDA. Whether you also hire a broker depends on how much of the process you want to run yourself.

Confidential inquiry

Tell us about your agency.

Everything you send stays between us. We never list or shop an agency, and nothing goes to a buyer without your explicit approval. There is no cost to you at any stage.